Agilent Companion Diagnostic Gains Expanded FDA Approval in Cervical Cancer
13 June 2018
Agilent Technologies Inc today announced that the U.S. Food and Drug Administration (FDA) has approved its Dako PD-L1 IHC 22C3 pharmDx assay for expanded use.
Physicians in the United Sta